Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and linked 'MedlinePlus Genetics'. The site revision was updated from 3.4.3 to 3.5.0.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a new revision label: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check59 days agoChange DetectedA new site revision was added (v3.4.2) and the older entry (v3.4.1) was removed; a government funding notice shown previously is no longer present. No study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check67 days agoChange DetectedA site-wide notice about government funding status was added and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check74 days agoChange DetectedAdded a Show glossary feature and updated the site revision to v3.4.0. The label for the last QC update was changed to 'Last Update Submitted that Met QC Criteria' and the 'No FEAR Act data' entry was removed.SummaryDifference0.2%

- Check81 days agoChange Detected- Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the study page. This may affect searchability and cross-linking to related resources, but does not alter the core trial details.SummaryDifference0.2%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.